论文信息 - Replacement Therapy with Virus-Inactivated Clotting Factor Concentrates in Patients with Severe Hemophilia in Heidelberg

Replacement Therapy with Virus-Inactivated Clotting Factor Concentrates in Patients with Severe Hemophilia in Heidelberg

Virus Safety of Hemophilia Treatment in Germany and Austria: A Tribute to Norbert Heimburger, Ph.D.; Editor in Chief, Eberhard F. Mammen, M.D.; Guest Editor, Hartmut Pollmann, M.D. Seminars in Thrombosis and Hemostasis, volume 28, supplement 1, 2002. Address for correspondence and reprint requests: Prof. Dr. med. Rainer Zimmermann, Kurpfalzkrankenhaus Heidelberg eGmbH, Bonhoefferstr. 5, 69123 Heidelberg, Germany. E-mail: rainer.zimmermann@kkh.srh.de. 1Kurpfalzkrankenhaus and Hemophilia Center and the SRH Group, Heidelberg, Germany. Copyright © 2002 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel: +1(212) 584-4662. 0094-6176,p;2002,28,s1,075,078,ftx,en;sth00805x. Replacement Therapy with Virus-Inactivated Clotting Factor Concentrates in Patients with Severe Hemophilia in Heidelberg

R. Zimmermann | A. Huth‐Kühne | C. Uhle

[1] T. Surowy,et al. An ELISA for detection of antibodies to the E2 protein of GB virus C. , 1997, The Journal of infectious diseases.

[2] K. Stark,et al. Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.

[3] P. Simmonds,et al. Heterogeneity of hepatitis C virus genotypes in hemophilia: relationship with chronic liver disease. , 1995, Blood.

[4] E. Holmes,et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. , 1993, The Journal of general virology.

[5] P. Mannucci,et al. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. , 1990, Annals of internal medicine.

[6] W. Stangel,et al. ANTIBODY TO HEPATITIS C VIRUS IN GERMAN BLOOD DONORS , 1989, The Lancet.

[7] U. Hasiba,et al. Chronic Liver Dysfunction in Multitransfused Hemophiliacs , 1977, Transfusion.

[8] C. Kasper,et al. Hepatitis and clotting-factor concentrates. , 1972, JAMA.

[9] P. Beeson. JAUNDICE OCCURRING ONE TO FOUR MONTHS AFTER TRANSFUSION OF BLOOD OR PLASMA: REPORT OF SEVEN CASES , 1943 .

[10] T. Pilot‐Matias,et al. Consensus oligonucleotide primers for the detection of GB virus C in human cryptogenic hepatitis. , 1996, Journal of virological methods.

[11] Suwarso. Virus Hepatitis-C , 1993 .